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Abstract Radiofrequency ablation (RFA) has become a
valuable therapeutic modality in cancer treatment over the
last decade. In orthopedic surgery, RFA is used for the
treatment of benign bone tumors and bone metastases.
Complications are rare and, to our knowledge, bone
fracture as a complication due solely to RFA has not been
reported to date. In this report we describe two patients with
a fracture in the calcar region of the femur as a
complication of RFA treatment for bone malignancies.
Since RFA is applied increasingly often, it is important to
report this risk of fracture as a complication of treatment of
lesions in the femoral calcar.
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Introduction
Radiofrequency ablation (RFA) has become a valuable
therapeutic modality in cancer treatment over the last
decade [1, 2]. RFA is a minimally invasive surgical
technique in which a high-frequency alternating current
heats tissue, resulting in tissue necrosis [3]. RFA is applied
in the treatment of both osseous tumors and soft-tissue
tumors. In orthopedic surgery, RFA is commonly used for
the treatment of osteoid osteoma. More recently, it is also
being used as a palliative measure for painful bone
metastases [4–7]. RFA provides excellent results, with
primary and secondary success rates of 79–96 and 97–
100%, respectively, for osteoid osteoma [6, 8–10]. In
addition, it has been demonstrated that the use of RFA
provides significant pain reduction in cancer patients with
bone metastases [11–13]. Complications are rare and are
mostly due to heat effects in surrounding tissues, such as
burning of the skin or cellulitis [8, 14, 15]. To our
knowledge, bone fracture as a complication merely due to
RFA has not been reported to date. In this report we
describe two patients with a fracture in the calcar region of
the femur as a complication of RFA treatment for bone
neoplasms. Both patients were informed that data
concerning their case would be submitted for publication.
Case reports
The first patient, a 52-year-old male, had an ill-understood
pain in the left groin for 2 years, worsening at night. He had
a psychiatric past with recurrent depression. The anesthe-
siologist and the neurologist could not find any abnormal-
ities and referred him to the department of orthopedic
surgery. There were no abnormalities in the left hip upon
physical examination. Technetium bone scan did not show
hot spots. MRI showed a small cyst-like lesion, which had
a benign appearance (Fig. 1). Given the fact that a
malignancy was very unlikely, the decision was made to
perform a biopsy followed by RFA. Ablation was reached
using a Soloist
tm single needle electrode (Boston Scientific,
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guidance (Fig. 2). The needle was inserted through a
4.5 mm access hole, and a field of 15–20 mm in diameter
was the anticipated size of the heated site. Ablation was
reached in three cycles of 5–7 min, starting with 2 W and
increasing by 1 W/min. Biopsies taken for histopathological
evaluation revealed that the lesion was a chondrosarcoma
(CS) grade I, which was a surprising finding. The patient
recovered from the procedure and was pain-free after
3 months. Initial weight-bearing was 10 kg for 6 weeks,
subsequently followed by 6 weeks of 50% body weight, for
a total 3-month period of partial weight-bearing. Although
clinical follow-up and MRI seemed unremarkable, the
patient developed a pathological fracture while climbing
up and down a ladder cleaning windows 3 months after the
RFA procedure (Fig. 3). The fracture occurred at the exact
location of the ablated lesion and could be seen retrospec-
tively on earlier MR images (Fig. 4). The patient underwent
surgery for total hip arthroplasty, with good clinical results
over 3 years of follow-up. Follow-up has shown neither
local tumor recurrence nor distant metastases in the lungs.
Fig. 1 MRI scan of the femoral head of patient 1 prior to surgery.
This 52-year-old man had suffered from groin pain for 2 years.
Differential diagnosis based on the small, cyst-like lesion (arrow)
includes bone cyst, enchondroma, and osteoid osteoma
Fig. 2 CT-guided radiofrequency ablation (RFA) of the lesion in the
collum femoris of patient 1. Following biopsy, the tip of the needle
(arrow) is percutaneously inserted in the lesion
Fig. 3 Plain X-ray of patient 1 3 months after RFA procedure. The
fracture occurred while the patient was climbing up and down a
ladder, and no trauma was involved
Fig. 4 MRI subtraction after 3 months showing the fracture of the
collum femoris at the site of the ablated lesion (small arrows) and
absence of uptake of contrast fluid in the lesion (large arrow),
indicating a successful RFA procedure
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surgery showed complete necrosis of tumor tissue at the site
of the thermal ablation, indicating a successful intervention
(Fig. 5).
The second patient is a 48-year-old female with a
follicular carcinoma of the thyroid with metastases in her
left and right femur. A pathological fracture had developed
in her left hip, which was initially treated with a gamma
n a i la n ds u b s e q u e n t l yr e p l a c e db yaG l o b a lM o d u l a r
Resection System (GMRS) tumor prosthesis (Stryker,
Limerick, Ireland). Follow-up with MRI showed a lesion
at the calcar region of her right femur (Fig. 6). For this
lesion, RFA with a LeVeen® umbrella needle (Boston
Scientific, Natick, MA, USA) under CT guidance was
applied. Dimensions of the access hole and the expected
ablated area were 4.5 mm and 20–30 mm in diameter,
respectively (Fig. 7). In a single cycle of 21 min, a
maximum of 20 W was delivered starting with 2 W and
adding 1 W/min. Three months after treatment, the patient
was pain-free with 50% weight-bearing, and MRI scans
showed no uptake of contrast fluid (Fig. 8). However, a few
days later the patient was admitted to our hospital with a
pathological fracture of her right hip at the site of the
previous ablation (Fig. 9). Retrospectively, no lesions could
be seen on the MR images that had been made a few days
Fig. 6 MRI of patient 2, a 48-year-old woman with a follicular
carcinoma of the thyroid. A lesion is shown in the calcar region of the
collum femoris (arrow) suspicious for bone metastasis
Fig. 7 RFA of the bone metastasis in the right collum femoris in
patient 2. Ablation was performed with a LeVeen umbrella needle
(Boston Scientific) (arrow)
Fig. 5 Representative histomorphology of the lesion in patient 1,
showing completely necrotic hyaline cartilaginous tumor tissue
surrounded by nonvital cancellous bone (magnified 40×)
Fig. 8 MRI subtraction showing absence of contrast fluid in the
ablated site (arrow) in patient 2, 3 months after the RFA procedure
Skeletal Radiol (2010) 39:1139–1143 1141earlier. Following diagnosis, the patient underwent total hip
surgery with good functional results until she died of her
primary disease, 2.5 years later. Histopathological analysis
of the retrieved femoral neck showed that apart from
necrosis, there was still viable tumor tissue in selected
slides of the tumor.
Discussion
In recent years, surgical excision has been replaced by RFA
for the treatment of osteoid osteoma and some skeletal
metastases. Because RFA is minimally invasive, precise,
inexpensive, and has a low complication rate, this
technique is gaining popularity and is being applied in an
increasing number of patients [14–17]. At our center, using
RFA under CT guidance, we have treated two patients with
neoplasms in the subcapital calcar region of the femur who
developed pathological fractures of the hip 3 months after
treatment.
Potentially, this region is generally more at risk for
fracturing, since fracturing after percutaneous cryotherapy
has also been reported in the collum femoris [18]. However,
heat conduction is very different from cold conduction and
there is sufficient experience with RFA in the treatment of
osteoid osteomas with only minor complications. We
therefore thought it would be safe to perform thermal
ablation in the first patient, yet the fracture occurred.
Presumably, there is a protective effect from the thick
sclerotic bone commonly surrounding an osteoid osteoma
that is absent in CS and bone metastases. We therefore
think that the risk of fracturing after RFA for malignancies
can not be extrapolated to cases of osteoid osteoma. In case
of bone metastases, we advocate ablating lesions only in the
center of the femoral neck. Lesions located near the
supporting cortex should only be ablated if hardware is
used for stabilisation.
One may argue the use of thermal ablation in the first
case, since RFA is not indicated for treatment of CS grade I.
However, RFA was applied in this case under the
suspection that the small lesion in the femoral head was
benign. In many such cases, biopsy fails to reveal
histological evidence and therefore the decision was made
to take the biopsy and perform RFA in the same session.
Although the size of the entrance, 4.5 mm, was larger than
necessary, we preferred to insert the RF needle through the
hole created by the biopsy needle.
Subsequent histology of material obtained with needle
biopsy during the RFA procedure revealed the presence of a
CS grade I, in which cure is intended either with curettage
and adjuvant cryosurgery or phenol, or with wide resection.
Generally, a CS grade I located at this site should have been
treated by femoral head resection with prosthetic recon-
struction. However, since the lesion was anticipated to be
benign, resection was thought to be too aggressive.
Although in retrospect RFA was not the correct option for
the treatment of the lesion, final histology of the femoral
head showed 100% lesion necrosis. Therefore it was
demonstrated that the RFA therapy had been rather
successful in terms of tumor ablation.
Considering the presence of a fracture on MR images
in patient 1, it was surprising that clinical follow-up was
quite unremarkable. The patient had only reported some
minor discomfort. However he was on partial weight-
bearing, which may have masked the presence of a
fracture.
With the fracture of the first patient in mind, the
possibility of the second patient developing a fracture was
taken into account. The decision to perform thermal
ablation was well calculated and the patient was compre-
hensively informed about the possible risks. The other
option, total hip arthroplasty, was not favorable in her
palliative setting and could still be performed if RFA
treatment failed or fracture occurred.
RFA has proven to be a safe treatment modality for
benign bone lesions and selected bone metastases. Since
RFA gives excellent clinical results, more challenging sites
are being treated, possibly leading to a higher number or
severity of complications. The occurrence of a fracture at
the calcar region of the femur after ablation in two
subsequent patients indicates that this site is at risk for
fracture after RFA treatment in malignant cases. Patients
should be well informed about this risk and the treating
physician should consider prophylactic internal fixation or
decreased weight-bearing for more than 3 months. Since
RFA is applied increasingly often, it is important to report
this risk of fracture as a complication of the treatment of
lesions in the femoral calcar.
Fig. 9 Pelvic X-ray, showing a subcapital fracture of the right collum
of patient 2, 3.5 months after thermal ablation
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